Etretinate in pustular psoriasis of palms and soles.

Author: MarksJ M, ShusterS, WhiteS I

Paper Details 
Original Abstract of the Article :
In a double-blind controlled study of patients with pustular psoriasis of palms and soles who were allocated at random to etretinate or placebo, we found that etretinate improved the condition as assessed by pustule count and overall clinical response. Side-effects occurred but were accepted by the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2133.1985.tb02382.x

データ提供:米国国立医学図書館(NLM)

Etretinate for Pustular Psoriasis: A Double-Blind Study

Dermatology is a field filled with intriguing puzzles, and the quest for effective treatments for psoriasis is one that has long captivated researchers. This study dives into the world of pustular psoriasis, a condition that can affect the palms and soles. The researchers conducted a double-blind, controlled trial to evaluate the efficacy of etretinate, a medication, in treating this specific type of psoriasis.

They meticulously divided participants into two groups: one receiving etretinate and the other receiving a placebo. The results were quite promising. Etretinate, the researchers observed, led to a notable improvement in the condition as measured by pustule count and overall clinical response. It’s like a thirsty traveler finding an oasis in the desert! However, it’s important to remember that the desert can be vast and unpredictable. Similarly, the long-term impact of etretinate remains to be fully explored. Further research is needed to determine the long-term efficacy and safety of etretinate in treating this type of psoriasis. We need to make sure that this oasis, while beautiful, is also sustainable!

Promising Results, But Long-Term Effects Remain a Mystery

The findings suggest that etretinate has the potential to bring relief to those suffering from pustular psoriasis of the palms and soles. However, there are a couple of key points to consider. First, the study looked at short-term effects. The long-term effectiveness of etretinate, like the endurance of a camel traversing the desert, needs to be examined further. Second, the study also highlighted the occurrence of side effects, though they were manageable in the short term.

A Balancing Act: Weighing Benefits and Risks

So, it’s like navigating a desert – you need to be cautious and prepared for any surprises. While etretinate shows promise for treating pustular psoriasis of the palms and soles, it’s important to weigh the potential benefits against the risks. Further research is essential to understand the long-term implications of etretinate use and ensure a safe and effective treatment journey for those battling this condition.

Dr. Camel's Conclusion

This study provides a ray of hope for individuals battling pustular psoriasis. Etretinate has the potential to bring relief, but like a camel navigating the desert, it’s important to be patient and understand the long-term implications of using this medication. Remember, the desert is a place of beauty and mystery, just like the world of medical research!

Date :
  1. Date Completed 1986-01-16
  2. Date Revised 2019-07-04
Further Info :

Pubmed ID

3904810

DOI: Digital Object Identifier

10.1111/j.1365-2133.1985.tb02382.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.